BMI1 and head and neck squamous cell carcinoma: MYCi975 plus cisplatin efficiently inhibited HNSCC; therefore, we used in vivo labeling of BMI1+ CSCs to determine whether the combination could efficiently eliminate BMI1+ CSCs, which play a critical role in HNSCC chemoresistance and relapse 15.